Profound Medical Corp PROF 深 沪
已收盘 03-27 16:00:00 美东时间
6.19
-0.110
-1.75%
华盛通- 最 高6.44
- 今 开6.19
- 成交量 23.59万股
- 最 低 5.94
- 昨 收 6.30
- 总市值 2.25亿
- 52周最高 8.95
- 市盈率 静 --
- 换手率 0.65%
- 52周最低 3.76
- 委 比 -79.59%
- 总股本 3629.36万
- 历史最高 28.97
- 量 比 0.50
- 振 幅 7.94%
- 历史最低 3.10
- 每 手 1
- 风险率 1.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
Toronto, March 27 - Profound Medical announced that Texas Prostate, led by Dr. James Cochran, has completed its 100th TULSA Procedure at Dallas Medical Center. The TULSA Procedure, utilizing real-time MRI guidance and thermography, offers enhanced precision and safety for treating prostate diseases. Since collaborating with Dallas Medical Center, Dr. Cochran saw a 500% increase in procedures, highlighting the procedure's versatility across prosta...
03-27 11:45
Top 3 Health Care Stocks That Are Set To Fly In March
Opportunity to buy undervalued health care stocks. RSI is a momentum indicator that compares strength on up and down days. Here's a list of oversold stocks with RSI near or below 30.
03-20 18:23
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Profound Medical Corp. announced the superior safety outcomes of the TULSA Procedure compared to robotic radical prostatectomy (RP) in men with localized prostate cancer in the CAPTAIN trial, exceeding enrollment targets with 211 patients. At 6 months, 50% of TULSA patients preserved erectile function and continence vs. 24% with RP (p<0.05). Urinary continence rates were 84% for TULSA vs. 49% for RP, and erectile function was preserved in 56% of ...
03-13 14:30
Profound Medical Earnings Call Maps Path to Profit
Profound Medical (($TSE:PRN)) has held its Q4 earnings call. Read on for the ma...
03-08 08:30
Profound Medical Q4 EPS $(0.27) Beats $(0.38) Estimate, Sales $5.977M Miss $10.532M Estimate.
Profound Medical (TSX:PRN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.38) by 28.95 percent. This is a 35 percent decrease over losses of $(0.20) per share from the
03-06 05:28
Profound Medical shares are trading lower after the company reported worse-than-expected Q4 financial results.
Profound Medical shares are trading lower after the company reported worse-than...
03-06 05:24
Earnings Summary: Profound Medical Q4
The Q4 earnings report for Profound Medical (NASDAQ:PROF) was released on Thurs...
03-06 05:08
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
Profound Medical's Earnings: A Preview
Profound Medical (NASDAQ:PROF) is set to give its latest quarterly earnings rep...
03-05 04:03
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion
An announcement from Profound Medical ( ($TSE:PRN) ) is now available. On Febru...
02-12 21:59
